Defining Patient-Centricity: Opportunities, Challenges, and Implications for Clinical Care and Research

被引:41
|
作者
Robbins, Dennis A. [1 ,2 ]
Curro, Frederick A. [2 ,3 ,4 ]
Fox, Chester H. [5 ,6 ]
机构
[1] Integrated Decis Eth Alternat & Solut, Imperial Beach, CA USA
[2] NYU, PEARL Practice Based Res Network, New York, NY 10003 USA
[3] Bluestone Ctr Clin Res, New York, NY USA
[4] NYU, Dept Oral & Maxillofacial Pathol Radiol & Med, New York, NY 10003 USA
[5] SUNY Buffalo, Dept Family Med, Sch Med & Biomed Sci, Buffalo, NY 14260 USA
[6] Upstate New York Practice Res Network UNYNET, New York, NY USA
关键词
patient-centricity; patient-centric; centricity; health literacy; PBRN; PCORI; CER; patient-centered; INHIBITORS;
D O I
10.1177/2168479013484159
中图分类号
R-058 [];
学科分类号
摘要
The Patient-Centered Outcomes Research Institute (PCORI), created and funded by the Affordable Care Act, is charged with bringing the patient perspective to clinical research design and the outcomes that are studied. However, there is no consensus definition of "patient-centeredness'' or "patient-centricity.'' This paper distinguishes between the terms and describes an infrastructure for supporting the concept of patient-centricity. The patient's role needs to be described in a way that makes it feasible to implement health care delivery and support parameters to conduct clinical research over a sustained period of time. The authors propose the use of a structured Practice-Based Clinical Research Network to perform patient-centered outcomes research consistent with the requirements of the pharmaceutical sector in a safe, ethical, and effective manner and congruent with the principles of Good Clinical Practice (GCP).
引用
收藏
页码:349 / 355
页数:7
相关论文
共 50 条
  • [41] Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities
    Xu, Zhijie
    Huang, Jinzhou
    Gao, Ming
    Guo, Guijie
    Zeng, Shuangshuang
    Chen, Xi
    Wang, Xiang
    Gong, Zhicheng
    Yan, Yuanliang
    GEROSCIENCE, 2021, 43 (02) : 487 - 505
  • [42] Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities
    Zhijie Xu
    Jinzhou Huang
    Ming Gao
    Guijie Guo
    Shuangshuang Zeng
    Xi Chen
    Xiang Wang
    Zhicheng Gong
    Yuanliang Yan
    GeroScience, 2021, 43 : 487 - 505
  • [43] Clinical Pharmacogenomics: Opportunities and Challenges at Point of Care
    Scott, S. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (01) : 33 - 35
  • [45] The human microbiome: opportunities and challenges for clinical care
    Rogers, G. B.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (09) : 889 - 898
  • [46] Enhancing Patient Centricity and Advancing Innovation in Clinical Research with Virtual Randomized Clinical Trials (vRCTs)
    Yaakov, Raphael A.
    Guler, Ozgur
    Mayhugh, Tim
    Serena, Thomas E.
    DIAGNOSTICS, 2021, 11 (02)
  • [47] Tumor banks and clinical research: challenges and opportunities
    Buyse, Marc
    BULLETIN DU CANCER, 2006, 93 : S237 - S240
  • [48] Opportunities and Challenges in microRNA Research and Clinical Application
    Klinge, Carolyn M.
    ENDOCRINOLOGY, 2023, 164 (09)
  • [49] Commentary - Opportunities and challenges in pediatric clinical research
    Beitins, IZ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12): : 4302 - 4306
  • [50] CURRENT CHALLENGES AND OPPORTUNITIES IN CLINICAL RESEARCH COMPLIANCE
    Portier, Wendy
    Dunne, Claire
    OCHSNER JOURNAL, 2006, 6 (01): : 21 - 24